BioSenic S.A. (0R55.L)

EUR 0.01

(-14.29%)

Long Term Debt Summary of BioSenic S.A.

BioSenic S.A.'s latest annual long term debt in 2023 was 15.57 Million EUR , down -1.29% from previous year.
BioSenic S.A.'s latest quarterly long term debt in 2024 Q2 was 22.6 Million EUR , down 0.0% from previous quarter.
BioSenic S.A. reported annual long term debt of 15.77 Million EUR in 2022, down -20.13% from previous year.
BioSenic S.A. reported annual long term debt of 19.75 Million EUR in 2021, up 68.53% from previous year.
BioSenic S.A. reported quarterly long term debt of 22.6 Million EUR for 2024 Q1, up 45.16% from previous quarter.
BioSenic S.A. reported quarterly long term debt of 16.34 Million EUR for 2023 Q3, up 4.1% from previous quarter.

Annual Long Term Debt Chart of BioSenic S.A. (2023 - 2011)

Historical Annual Long Term Debt of BioSenic S.A. (2023 - 2011)

Year	Long Term Debt	Long Term Debt Growth
2023	15.57 Million EUR	-1.29%
2022	15.77 Million EUR	-20.13%
2021	19.75 Million EUR	68.53%
2020	11.72 Million EUR	6.5%
2019	11 Million EUR	7.4%
2018	10.24 Million EUR	-2.88%
2017	10.55 Million EUR	-5.52%
2016	11.16 Million EUR	10.36%
2015	10.11 Million EUR	73.66%
2014	5.82 Million EUR	15.34%
2013	5.05 Million EUR	22.77%
2012	4.11 Million EUR	33.17%
2011	3.09 Million EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 Q2	22.6 Million EUR	0.0%
2024 Q1	22.6 Million EUR	45.16%
2023 Q3	16.34 Million EUR	4.1%
2023 Q4	15.57 Million EUR	-4.69%
2023 Q1	15.69 Million EUR	-0.51%
2023 Q2	15.69 Million EUR	0.0%
2023 FY	15.57 Million EUR	-1.29%
2022 Q3	15.77 Million EUR	5.17%
2022 FY	15.77 Million EUR	-20.13%
2022 Q4	15.77 Million EUR	-0.02%
2022 Q2	15 Million EUR	0.0%
2021 Q2	11.71 Million EUR	0.0%
2021 Q4	19.75 Million EUR	0.0%
2021 FY	19.75 Million EUR	68.53%
2020 Q2	14.93 Million EUR	0.0%
2020 FY	11.72 Million EUR	6.5%
2020 Q4	11.72 Million EUR	0.0%
2019 FY	11 Million EUR	7.4%
2019 Q2	12.75 Million EUR	0.0%
2019 Q4	11 Million EUR	0.0%
2018 FY	10.24 Million EUR	-2.88%
2018 Q4	10.24 Million EUR	0.0%
2018 Q2	9.73 Million EUR	0.0%
2017 FY	10.55 Million EUR	-5.52%
2017 Q4	10.55 Million EUR	0.0%
2017 Q2	10.43 Million EUR	0.0%
2016 Q4	11.16 Million EUR	0.0%
2016 Q2	10.1 Million EUR	0.0%
2016 FY	11.16 Million EUR	10.36%
2015 Q2	5.44 Million EUR	0.0%
2015 FY	10.11 Million EUR	73.66%
2015 Q4	10.11 Million EUR	0.0%
2014 FY	5.82 Million EUR	15.34%
2014 Q4	5.82 Million EUR	14.66%
2014 Q3	5.08 Million EUR	0.0%
2013 Q4	5.05 Million EUR	0.0%
2013 FY	5.05 Million EUR	22.77%
2012 FY	4.11 Million EUR	33.17%
2011 FY	3.09 Million EUR	0.0%

Peer Long Term Debt Comparison of BioSenic S.A.

Name	Long Term Debt	Long Term Debt Difference
Boiron SA	6.64 Million EUR	-134.357%
Laboratorios Farmaceuticos Rovi, S.A.	38.57 Million EUR	59.629%
Vetoquinol SA	9.66 Million EUR	-61.161%
Valneva SE	132.76 Million EUR	88.271%
AB Science S.A.	16.98 Million EUR	8.329%
Nanobiotix S.A.	41.66 Million EUR	62.619%
PHAXIAM Therapeutics S.A.	7.03 Million EUR	-121.522%
Vivoryon Therapeutics N.V.	- EUR	-Infinity%
ABIVAX Société Anonyme	44.69 Million EUR	65.159%
Formycon AG	7.81 Million EUR	-99.271%